aidot

Cerviray AI is used in the VIA (Visual Inspection with Acetic-acid) method

[View original text]

12th of May, AIDOT (CEO Jae-hoon Jeong) announced that Cerviray AI’s license from Uzbekistan’s MOH (Ministry of Health) was registered on 27th of April.

This licensing and registration was made at the request of the Uzbekistan National Cancer Center (Republican specialized Scientific and practical Medical Center of Oncology and 

Radiology). AIDOT recently signed a supply contract with GSG Group in Uzbekistan.

With this contract, the construction of a camera and server system for examination using Amazon Web Services (AWS) was completed, and 6,600 pilot tests are currently being 

conducted using this system. Once the test is completed and commercialization begins, the cervical cancer screening service will be expanded to all regions of Uzbekistan.

Uzbekistan mainly used human papillomavirus (HPV) testing for cervical cancer screening. However, Uzbek authorities had difficulty expanding the scale of HPV testing due to cost issues, such as testing facilities for collected samples and training of experts. Cerviray AI has quickly emerged as an alternative to existing tests as it can perform examinations 

anywhere in an environment where the Internet is available.

On 12th of April, AIDOT held the Global Web-seminar of Cerviray at the request of the National Cancer Center of Uzbekistan.

This seminar introduced the journal 'Role of Artificial Intelligence Interpretation of Colposcopic Images in Cervical Cancer Screening', which states that artificial intelligence increases the accuracy of cervical cancer screening. Lectures were given on the correct use of Cerviray AI and how artificial intelligence is used for cervical cancer screening.

“Through this seminar, we showed local medical staff in Uzbekistan that cervical cancer screening using artificial intelligence can be a new alternative to supplement or replace 

existing screening methods,” said Chan Hur, deputy head of AIDOT Global Sales and Marketing Team. Through the seminar, we are trying to provide a wide range of cervical cancer 

screening services to women in Uzbekistan.”

Overview of AIDOT Inc.

Since its foundation in June 2014, AIDOT has been recognized for its technology, including KIC China, Incheon Creative Economy Innovation Center, and various government projects. Also, has developed an artificial intelligence-based cervical cancer reading system called "Cerviray AI." In addition, medical artificial intelligence products such as △ carotid ultrasound AI △ liver disease diagnosis AI △ stomach and colonoscopy AI △ capsule endoscope AI △ ureter stone AI have been developed and are entering the Chinese and Southeast Asian 

markets.

12th. May. 2022. / International Internet Newspaper